Alkem Laboratories has announced the release of the audio recording for its Q2 and H1 FY26 Earnings Conference Call. The announcement was made on November 13, 2025, in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Investors and stakeholders can access the recording via the company’s official website at https://www.alkemlabs.com/investors/earnings-call. This initiative aims to provide greater transparency and insight into the company’s financial performance during the second quarter and the first half of the fiscal year.

In the communication addressed to the BSE Limited and the National Stock Exchange of India Limited, Alkem Laboratories emphasized the importance of this earnings call for investors. The call is expected to highlight key financial metrics, strategic updates, and future outlooks that impact the company’s operations and market position. The scrip code for BSE is 539523 and the scrip symbol for NSE is ALKEM, allowing investors to easily track the company's performance on the stock exchanges. This move underscores Alkem's commitment to keeping its stakeholders informed and engaged.